Polymer Laboratories Inc - - BioPharm International

ADVERTISEMENT

Polymer Laboratories Inc

BioPharm International
Volume 18, Issue 12

Company Description



Polymer Laboratories (PL) specializes in developing and manufacturing high-grade polymeric particles for HPLC columns (nano through process-scale), solid- and solution-phase synthesis supports for high throughput organic synthesis and peptide synthesis; and polymers for clinical diagnostics, including paramagnetic particles for bioseparations.

PL's media and resins are manufactured under the ISO 9001:2000 Quality Management System.The company has 29 years' experience in polymers and polymer particles for high-technology applications.



PL is an international company with offices and laboratories in the US and Europe which, together with an established global distributor network, offer worldwide sales, technical support, and service.

Chief Biopharmaceutical Techniques Supported

  • Synthesis
  • Analysis
  • Purification

Facilities



State-of-the-art manufacturing facilities opened in 2001, with a capacity greater than 4 M tons of high- performance particles, establishing PL as one of the world's largest chromatographic and solid phase synthesis particle manufacturers. The company's facilities are ISO 9001:2000 accredited.

PL also provides stringently controlled specialized production of particles for biological applications.

Major Products

  • HPLC columns and media
  • Synthesis supports
  • Paramagnetic particles

Markets Served

  • Biotherapeutic synthesis and purification
  • Biomolecule synthesis and purification
  • Diagnostics

POLYMER LABORATORIES INC
Amherst Fields Research Park 160 Old Farm Road, Amherst, MA 01002

TELEPHONE
413.253.9554

FAX
413.253.2476

E-MAIL

WEB ADDRESS
http://www.polymerlabs.com/

EMPLOYEES
175 worldwide

FOUNDED
1976

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here